Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma Medical Health News, 26 Mar 2019 To date, clinical data on ICIs in PeM remain quite sparse. While some trials have demonstrated efficacy of anti-PD-1 and anti-PD…